Rail Vision (Nasdaq: RVSN), a technology company that is seeking to revolutionize railway safety and the data-related market, successfully demonstrated the field applicability of its innovative Switch Yard System for a Class 1 North American railroad. The demonstration showcased Rail Vision’s technology on an SD40 locomotive equipped with autonomous driving technology and an advanced electronic air brake system. In wet and foggy weather, Rail Vision’s obstacle detection system enabled the locomotive to efficiently navigate numerous challenging obstacles during both conventional and autonomous operations. The demonstration achieved GoA4 status. GoA4, which requires no on-train staff, is the highest level of automated train operations.

Recruiter.com (Nasdaq: RCRT), an on-demand recruiting platform, announced a strategic client partnership with FIRST, a leading global brand experience agency, to help grow specialist talent on their client's team. FIRST is a leading brand experience agency with a global presence, serving clients in various industries, including financial services, technology, media, consumer electronics, medical and healthcare, automotive, aerospace, and the nonprofit sector.

Sharps Technology (Nasdaq: STSS), an innovative medical device and drug delivery Company offering patented, best-in-class syringe products, announced the advancement of the Company's specialized prefillable syringe ("PFS") system product line, which will be manufactured in collaboration with Nephron Pharmaceuticals at the Inject EZ facility in West Columbia, South Carolina.

Can-Fite BioPharma (NYSE American: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, submitted a market registration plan to the European Medicines Agency (EMA) for its lead drug candidate Piclidenoson in the treatment of moderate to severe psoriasis. A submission to the U.S. Food and Drug Administration (FDA) will follow.